. American-psychiatric-association, Practice guideline for the treatment of patients with major depressive disorder, 2010.

I. Anderson, I. Ferrier, and R. Baldwin, Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the, 2000.

D. Baldwin, D. Stein, O. Dolberg, and B. Bandelow, How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database, Human Psychopharmacology: Clinical and Experimental, vol.159, issue.Suppl, pp.269-75, 2009.
DOI : 10.1002/hup.1019

M. Bares, T. Novak, M. Kopecek, P. Stopkova, and J. Kozeny, The early improvement of depressive symptoms as a potential predictor of response to antidepressants in depressive patients who failed to respond to previous antidepressant treatments. Analysis of naturalistic data, European Psychiatry, vol.27, issue.7, pp.522-529, 2012.
DOI : 10.1016/j.eurpsy.2011.05.002

M. Bauer, P. Whybrow, J. Angst, M. Versiani, and H. Moller, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder, The World Journal of Biological Psychiatry, vol.34, issue.3, pp.5-43, 2002.
DOI : 10.1001/archpsyc.58.1.55

P. Bech, P. Cialdella, and M. Haugh, Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression, The British Journal of Psychiatry, vol.176, issue.5, pp.421-429, 2000.
DOI : 10.1192/bjp.176.5.421

P. Bech, Social Functioning, CNS Drugs, vol.4, issue.3, pp.313-337, 2005.
DOI : 10.2165/00023210-200519040-00004

D. Bonett and R. Price, Statistical Inference for Generalized Yule Coefficients in 2 ?? 2 Contingency Tables, Sociological Methods & Research, vol.75, issue.3, pp.429-475, 2007.
DOI : 10.1177/0049124106292358

R. Casper, M. Katz, C. Bowden, J. Davis, S. Koslow et al., The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine, Journal of Affective Disorders, vol.31, issue.3, pp.151-64, 1994.
DOI : 10.1016/0165-0327(94)90024-8

W. Coryell, A. Coppen, V. Zeigler, and J. Biggs, Early improvement as a predictor of response to amitriptyline and nortriptyline: a comparison of 2 patient samples, Psychological Medicine, vol.120, issue.01, pp.135-144, 1982.
DOI : 10.1016/S0140-6736(78)90003-X

A. Gelenberg and C. Chesen, How Fast Are Antidepressants?, The Journal of Clinical Psychiatry, vol.61, issue.10, pp.712-733, 2000.
DOI : 10.4088/JCP.v61n1002

P. Gorwood, E. Corruble, B. Falissard, and G. Goodwin, Toxic Effects of Depression on Brain Function: Impairment of Delayed Recall and the Cumulative Length of Depressive Disorder in a Large Sample of Depressed Outpatients, American Journal of Psychiatry, vol.165, issue.6, pp.731-740, 2008.
DOI : 10.1176/appi.ajp.2008.07040574

P. Gorwood, Review: Restoring circadian rhythms: a new way to successfully manage depression, Journal of Psychopharmacology, vol.24, issue.2 Suppl, pp.15-24, 2010.
DOI : 10.1177/1359786810372981

M. Hamilton, A RATING SCALE FOR DEPRESSION, Journal of Neurology, Neurosurgery & Psychiatry, vol.23, issue.1, pp.56-62, 1960.
DOI : 10.1136/jnnp.23.1.56

V. Henkel, F. Seemuller, and M. Obermeier, Does early improvement triggered by antidepressants predict response/remission? ??? Analysis of data from a naturalistic study on a large sample of inpatients with major depression, Journal of Affective Disorders, vol.115, issue.3, pp.439-488, 2009.
DOI : 10.1016/j.jad.2008.10.011

I. Hickie and N. Rogers, Novel melatonin-based therapies: potential advances in the treatment of major depression, The Lancet, vol.378, issue.9791, pp.621-652, 2011.
DOI : 10.1016/S0140-6736(11)60095-0

R. Hirschfeld, D. Dunner, G. Keitner, D. Klein, L. Koran et al., Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination, Biological Psychiatry, vol.51, issue.2, pp.123-156, 2002.
DOI : 10.1016/S0006-3223(01)01291-4

K. Howard, R. Lueger, M. Maling, and Z. Martinovich, A phase model of psychotherapy outcome: Causal mediation of change., Journal of Consulting and Clinical Psychology, vol.61, issue.4, pp.678-85, 1993.
DOI : 10.1037/0022-006X.61.4.678

M. Katz, S. Koslow, and J. Maas, The timing, specificity and clinical prediction of tricyclic drug effects in depression, Psychological Medicine, vol.12, issue.02, pp.297-309, 1987.
DOI : 10.1192/bjp.143.6.601

S. Kennedy and R. Emsley, Placebo-controlled trial of agomelatine in the treatment of major depressive disorder, European Neuropsychopharmacology, vol.16, issue.2, pp.93-100, 2006.
DOI : 10.1016/j.euroneuro.2005.09.002

R. Kessler, S. Aguilar-gaxiola, and J. Alonso, The global burden of mental disorders: An update from the WHO World Mental Health (WMH) Surveys, Epidemiologia e Psichiatria Sociale, vol.49, issue.01, pp.23-33, 2009.
DOI : 10.1192/bjp.188.5.465

J. Kim, S. Kim, and R. Stewart, Improvement within 2weeks and later treatment outcomes in patients with depressive disorders: The CRESCEND study, Journal of Affective Disorders, vol.129, issue.1-3, pp.183-90, 2011.
DOI : 10.1016/j.jad.2010.09.007

R. Lam, S. Kennedy, and S. Grigoriadis, Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults., Journal of Affective Disorders, vol.117, pp.26-43, 2009.
DOI : 10.1016/j.jad.2009.06.041

A. Leuchter, S. Uijtdehaage, I. Cook, O. Hara, R. Mandelkern et al., Relationship between brain electrical activity and cortical perfusion in normal subjects, Psychiatry Research: Neuroimaging, vol.90, issue.2, pp.125-165, 1999.
DOI : 10.1016/S0925-4927(99)00006-2

J. Li, A. Kuk, and A. Rush, A practical approach to the early identification of antidepressant medication non-responders, Psychological Medicine, vol.36, issue.02, pp.309-325, 2012.
DOI : 10.1176/appi.ajp.160.4.734

H. Lôo, A. Hale, D. Haenen, and H. , Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study, Int Clin Psychopharmacol, vol.17, pp.239-286, 2002.

L. Marangell, Switching antidepressants for treatment-resistant major depression, J Clin Psychiatry, vol.62, pp.12-19, 2001.

A. Nierenberg, N. Mclean, J. Alpert, J. Worthington, J. Rosenbaum et al., Early non-response to fluoxetine as a predictor of poor 8-week outcome, Am J Psychiatry, vol.152, pp.1500-1503, 1995.

A. Nierenberg, J. Greist, . Mallinckrodt-c, A. Prakash, A. Sambunaris et al., Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study, Current Medical Research and Opinion, vol.23, issue.2, pp.401-417, 2007.
DOI : 10.1185/030079906X167453

J. Olesen, A. Gustavsson, M. Svensson, and H. Wittchen, The economic cost of brain disorders in Europe, European Journal of Neurology, vol.21, issue.Suppl. 14, pp.155-62, 2012.
DOI : 10.1111/j.1468-1331.2011.03590.x

J. Olié and S. Kasper, Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5- HT2C antagonistic properties, in major depressive disorder, Int J Neuropsychopharmacol, vol.10, pp.661-73, 2007.

G. Papakostas and M. Fava, Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD, European Neuropsychopharmacology, vol.19, issue.1, pp.34-40, 2009.
DOI : 10.1016/j.euroneuro.2008.08.009

A. Parrott and I. Hindmarch, The leeds sleep evaluation questionnaire in psychopharmacological investigations?a review, Psychopharmacology, vol.110, issue.Suppl, pp.173-182, 1980.
DOI : 10.1007/BF00434408

M. Posternak and M. Zimmerman, Is There a Delay in the Antidepressant Effect? A Meta-Analysis, The Journal of Clinical Psychiatry, vol.66, issue.02, pp.148-58, 2005.
DOI : 10.4088/JCP.v66n0201

F. Quitkin, J. Rabkin, J. Markowitz, J. Stewart, P. Mcgrath et al., Use of Pattern Analysis to Identify True Drug Response, Archives of General Psychiatry, vol.44, issue.3, pp.259-64, 1987.
DOI : 10.1001/archpsyc.1987.01800150071009

M. Rosenberg, D. Adams, J. M. Gurevitch, and . Win, Statistical software for metaanalysis . Version 2. Sunderland: Massachusetts: Sinauer Associates, 2000.

P. Rothwell, External validity of randomised controlled trials: ???To whom do the results of this trial apply????, The Lancet, vol.365, issue.9453, pp.82-93, 2005.
DOI : 10.1016/S0140-6736(04)17670-8

A. Rush, M. Trivedi, and H. Ibrahim, The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression, Biological Psychiatry, vol.54, issue.5, pp.573-83, 2003.
DOI : 10.1016/S0006-3223(02)01866-8

A. Rush, M. Trivedi, and S. Wisniewski, Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression, New England Journal of Medicine, vol.354, issue.12, pp.1231-1273, 2006.
DOI : 10.1056/NEJMoa052963

D. Sheehan, K. Harnett-sheehan, and R. Ba, The measurement of disability, International Clinical Psychopharmacology, vol.11, issue.Supplement 3, pp.89-95, 1996.
DOI : 10.1097/00004850-199606003-00015

V. Srinivasan, D. Berardis, D. Shillcutt, S. Brzezinski, and A. , Role of melatonin in mood disorders and the antidepressant effects of agomelatine, Expert Opinion on Investigational Drugs, vol.21, issue.1, pp.1503-1525, 2012.
DOI : 10.1097/FBP.0b013e3280116e5c

H. Stassen, J. Angst, and A. Delini-stula, Onset of improvement under fluoxetine and moclobemide, European Psychiatry, vol.13, issue.3, pp.128-161, 1998.
DOI : 10.1016/S0924-9338(98)80135-1

D. Stroup, J. Berlin, S. Morton, I. Olkin, G. Williamson et al., Metaanalysis of observational studies in epidemiology: a proposal for reporting

K. Swanson, R. Bastani, L. Rubenstein, L. Meredith, and D. Ford, Effect of Mental Health Care and Shared Decision Making on Patient Satisfaction in a Community Sample of Patients with Depression, Medical Care Research and Review, vol.64, issue.4, pp.416-446, 2007.
DOI : 10.1177/1077558707299479

A. Szegedi, W. Jansen, A. Van-willigenburg, E. Van-der-meulen, H. Stassen et al., Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.70, issue.3, pp.344-53, 2009.
DOI : 10.4088/JCP.07m03780

. Tadic´atadic´tadic´a, I. Helmreich, and R. Mergl, Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression, Journal of Affective Disorders, vol.120, issue.1-3, pp.86-93, 2010.
DOI : 10.1016/j.jad.2009.04.014

. Tadic´atadic´tadic´a, S. Wagner, S. Gorbulev, N. Dahmen, C. Hiemke et al., Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder, BMC Psychiatry, vol.44, issue.Suppl. 4, p.16, 2011.
DOI : 10.1159/000318162

G. Thornicroft and N. Sartorius, The course and outcome of depression in different cultures: 10-year follow-up of the WHO Collaborative Study on the Assessment of Depressive Disorders, Psychological Medicine, vol.172, issue.04, pp.1023-1055, 1993.
DOI : 10.1192/bjp.153.6.752

M. Trivedi, A. Rush, and S. Wisniewski, Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice, American Journal of Psychiatry, vol.163, issue.1, pp.28-40, 2006.
DOI : 10.1176/appi.ajp.163.1.28

D. Van-calker, I. Zobel, P. Dykierek, P. Deimel, S. Kech et al., Time course of response to antidepressants: Predictive value of early improvement and effect of additional psychotherapy, Journal of Affective Disorders, vol.114, issue.1-3, pp.243-53, 2009.
DOI : 10.1016/j.jad.2008.07.023

A. Wade, F. Andersen, and H. , The onset of effect for escitalopram and its relevance for the clinical management of depression, Current Medical Research and Opinion, vol.22, issue.11, pp.2101-2111, 2006.
DOI : 10.1185/030079906X148319

B. Walsh, S. Seidman, R. Sysko, and M. Gould, Placebo Response in Studies of Major Depression, JAMA, vol.287, issue.14, pp.1840-1847, 2002.
DOI : 10.1001/jama.287.14.1840

G. Winokur, What to do? Or what do we owe our residents?, Biol Psychiatry, vol.15, pp.599-611, 1980.